凝血酶/抗凝血酶復(fù)合體(TAT)單克隆抗體
Monoclonal Antibody to Thrombin/Antithrombin Complex (TAT)
- 編號MAA831Hu23
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(克隆號)C7
- Ig亞型 IgG1 Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標記物無標記物
- 免疫原 RPA831Hu01-凝血酶/抗凝血酶復(fù)合體(TAT)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液(pH7.4,containing 0.05% Proclin-300,50% glycerol)
- 性狀液體
- 濃度1mg/ml
- 且適物種-
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術(shù),請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 1179 ¥ 2751 ¥ 3930 ¥ 9825 ¥ 39300
- 欲了解實際交易價格和更多情況,請與當?shù)亟?jīng)銷商聯(lián)系!
特異性
該抗體是針對TAT的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別TAT。
用法
Western blotting: 0.5-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當?shù)臈l件下存儲,損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
EPA831Hu61 | 凝血酶/抗凝血酶復(fù)合體(TAT)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA831Hu01 | 凝血酶/抗凝血酶復(fù)合體(TAT)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
MAA831Hu21 | 凝血酶/抗凝血酶復(fù)合體(TAT)單克隆抗體 | WB |
MAA831Hu24 | 凝血酶/抗凝血酶復(fù)合體(TAT)單克隆抗體 | WB; IHC; ICC; IP. |
MAA831Hu25 | 凝血酶/抗凝血酶復(fù)合體(TAT)單克隆抗體 | WB; IHC; ICC; IP. |
MAA831Hu22 | 凝血酶/抗凝血酶復(fù)合體(TAT)單克隆抗體 | WB; IHC; ICC; IP. |
MAA831Hu23 | 凝血酶/抗凝血酶復(fù)合體(TAT)單克隆抗體 | WB; IHC; ICC; IP. |
MAA831Hu27 | 凝血酶/抗凝血酶復(fù)合體(TAT)單克隆抗體 | WB; IHC; ICC; IP. |
SEA831Hu | 凝血酶/抗凝血酶復(fù)合體(TAT)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA831Hu | 凝血酶/抗凝血酶復(fù)合體(TAT)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
雜志 | 參考文獻 |
IUBMB LIFE | Genetic repression of mouse VEGF expression regulates coagulation cascade. [PubMed: 21086498] |
Thrombosis Research | Treatment with unfractionated heparin attenuates coagulation and inflammation in endotoxemic mice [ScienceDirect: S0049384811004166] |
Journal of Thrombosis and Haemostasis | High sCD40L levels early after trauma are associated with enhanced shock, sympathoadrenal activation, tissue and endothelial damage, coagulopathy and mortality [Wiley: source] |
3 | Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling [Nature: 20120329] |
Am J Respir Cell Mol Bio | Prolonged Exposure to Sphingosine 1–Phosphate Receptor-1 Agonists Exacerbates Vascular Leak, Fibrosis, and Mortality after Lung Injury [PubMed: PMC2993087] |
PLoS One | Host Defense Peptides of Thrombin Modulate Inflammation and Coagulation in Endotoxin-Mediated Shock and Pseudomonas aeruginosa Sepsis [PubMed: PMC3521733] |
Haemetology | Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India [Pubmed: 23992124] |
Am J Transl Res. | Selected hemostatic parameters in patients with pancreatic tumors. [Pubmed:Pmc4297344] |
PLOS ONE | TFPI1 Mediates Resistance to Doxorubicin in Breast Cancer Cells by Inducing a Hypoxic-Like Response [Pubmed:24489651] |
Leukemia | Novel evidence that crosstalk between the complement, coagulation and fibrinolysis proteolytic cascades is involved in mobilization of hematopoietic stem/progenitor cells (HSPCs) [Pubmed:24667943] |
Anesthesia & Analgesia | Thrombomodulin Improved Liver Injury, Coagulopathy, and Mortality in an Experimental Heatstroke Model in Mice [Pubmed:24781566] |
Cell Transplantation | Evidence of a Pivotal Role for the Distal Part of the Complement Cascade in the Diurnal Release of Hematopoietic Stem Cells Into Peripheral Blood [Pubmed:26087465] |
European Journal of Pharmacology | (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coaCavia (Guinea pig )lation [Pubmed:27343380] |
J Thromb Haemost. | Coagulation factor XI vaccination: an alternative strategy to prevent thrombosis. [pubmed:27813324] |
Blood Cells, Inflammation and Infection | Nebulized Heparin Attenuates Pulmonary Coagulopathy and Inflammation through Alveolar Macrophages in a Rat Model of Acute Lung Injury [pubmed:29202212] |
SCIENCE TRANSLATIONAL MEDICINE | Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertension [pubmed:28148841] |
32 | Activated TAFI Promotes the Development of Chronic Thromboembolic Pulmonary Hypertension: A Possible Novel Therapeutic Target [pubmed:28289017] |
Thrombosis?andHaemostasis | Nebulized anti-coagulants as a therapy for acute lung injury and acute respiratory distress syndrome [Pubmed: 29202212] |
Thrombosis Research | The circadian rhythm of selected parameters of the hemostasis system in healthy people [] |
Experimental Neurobiology | Transduced Tat-aldose Reductase Protects Hippocampal Neuronal Cells against Oxidative Stress-induced Damage [Pubmed: 31698553] |
LIVER TRANSPLANTATION | The impact of dabigatran treatment on sinusoidal protection against hepatic ischemia‐reperfusion injury in mice [Pubmed: 33108682] |
Am J Physiol Heart Circ Physiol | Doxorubicin contributes to thrombus formation and vascular injury via enhancing platelet functions in vivo [Pubmed: 32469636] |
Intensive Care Medicine Experimental | Preservation of renal endothelial integrity and reduction of renal edema by aprotinin does not preserve renal perfusion and function following experimental?… [34169407] |
Intensive Care Med Exp | Complement factor D is linked to platelet activation in human and rodent sepsis [34396466] |
留言咨詢